수지상세포의 항원제시 능력 및 항암활성에 미치는 Lipofectin의 영향

참고문헌 (27)

1. "Dendritic cells and the control of immunity", 392, pp.245~252 (1998)
2. "Immunobiology of dendritic cells", 18, pp.767~811 (2000)
3. "Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype", 90, pp.1920~1926 (1997)
4. "Dendritic cell based tumor vaccines", 74, pp.5~10 (2000)
5. "Dendritic cell biology and cancer therapy", 53, pp.240~248 (2004)
6. "Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA", 101, pp.977~982 (2003)
7. "The use of dendritic cells in cancer immunotherapy", 15, pp.138~147 (2003)
8. "IL-12 production and subsequent natural killer cell activation by necrotic tumor cell-loaded dendritic cells in therapeutic vaccinations", 3, pp.188~200 (2003)
9. "Introduction of soluble- protein into the class-I pathway of antigen processing and presentation", 54, pp.777~785 (1988)
10. "Detection of rare antigen- presenting cells by the LacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens", 89, pp.6020~6024 (1992)
11. "Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules", 158, pp.2723~2730 (1997)
12. "Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with mouse bone marrow cultures supplemented with granulocyte", macrophage colony-stimulating factor, 1992, pp.176, 1693~1702
13. "Endogenous generation and presentation of the ovalbumin peptide", k complex to T-cells, 1993, pp.j immu(l 150), 2724~2736
14. "Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination", 36, pp.428~443 (2004)
15. "Induction of antitumor immunity using bone marrow-generated dendritic cells", 156, pp.2918~2926 (1996)
16. "Retrovirally transduced bone marrow-derived dendritic cells require CD4 T cell help to elicit protective and therapeutic antitumor immunity", 162, pp.144~151 (1999)
17. "A new era for cancer immunotherapy based on the genes that encode cancer antigens", 10, pp.281~287 (1999)
18. "Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells", 27, pp.280~288 (1997)
19. "Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules", 158, pp.2723~2730 (1997)
20. "Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment:downregulation by cytokines and bacterial products", 182, pp.389~400 (1995)
21. "Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells", 1, pp.362~368 (1999)
22. "Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens", 84, pp.1564~1570 (2001)
23. "Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination", 53, pp.963~977 (2004)
24. "Coupling of antigen to cholera toxin for dendritic cell vaccination promotes the induction of MHC class I-restricted cytotoxic T cells and the rejection of a cognate antigen-expressing model tumor", 34, pp.1272~1281 (2004)
25. "Dendritic cells loaded with exogenous antigen by electroporation can enhance MHC class I-mediated antitumor immunity", 53, pp.315~522 (2004)
26. "Virosome-mediated delivery of protein antigens to dendritic cells", 20, pp.2287~2295 (2002)
27. "Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway", 30, pp.1740~1747 (2000)

관련 논문AI추천